Title

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Document Type

Journal Article

Role

author

Standard Number

0006-4971

Journal Title

Blood

Volume

111

First Page

5663

Last Page

5671

Publication Date

2008

Share

COinS